Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Sci Rep ; 6: 29094, 2016 07 08.
Article in English | MEDLINE | ID: mdl-27388805

ABSTRACT

Sweet perception promotes food intake, whereas that of bitterness is inhibitory. Surprisingly, the expression of sweet G protein-coupled taste receptor (GPCTR) subunits (T1R2 and T1R3) and bitter GPCTRs (T2R116, T2R118, T2R138 and T2R104), as well as the α-subunits of the associated signalling complex (αGustducin, Gα14 and αTransducin), in oral and extra-oral tissues from lean and obese mice, remains poorly characterized. We focused on the impact of obesity on taste receptor expression in brain areas involved in energy homeostasis, namely the hypothalamus and brainstem. We demonstrate that many of the GPCTRs and α-subunits are co-expressed in these tissues and that obesity decreases expression of T1R3, T2R116, Gα14, αTrans and TRPM5. In vitro high levels of glucose caused a prominent down-regulation of T1R2 and Gα14 expression in cultured hypothalamic neuronal cells, leptin caused a transient down-regulation of T1R2 and T1R3 expression. Intriguingly, expression differences were also observed in other extra-oral tissues of lean and obese mice, most strikingly in the duodenum where obesity reduced the expression of most bitter and sweet receptors. In conclusion, obesity influences components of sweet and bitter taste sensing in the duodenum as well as regions of the mouse brain involved in energy homeostasis, including hypothalamus and brainstem.


Subject(s)
Brain Stem/metabolism , Duodenum/metabolism , Hypothalamus/metabolism , Obesity/genetics , Receptors, G-Protein-Coupled/genetics , Animals , Brain Stem/pathology , Duodenum/pathology , Energy Metabolism/genetics , GTP-Binding Protein alpha Subunits, Gq-G11/genetics , GTP-Binding Protein alpha Subunits, Gq-G11/metabolism , Gene Expression Regulation , Glucose/metabolism , Glucose/pharmacology , Homeostasis/genetics , Hypothalamus/pathology , Leptin/metabolism , Leptin/pharmacology , Mice , Mice, Inbred C57BL , Mice, Obese , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Obesity/metabolism , Obesity/pathology , Primary Cell Culture , Protein Isoforms/genetics , Protein Isoforms/metabolism , Receptors, G-Protein-Coupled/metabolism , Signal Transduction , TRPM Cation Channels/genetics , TRPM Cation Channels/metabolism , Taste/genetics , Taste Buds/metabolism , Taste Buds/pathology
2.
Eur J Clin Invest ; 35(2): 82-92; discussion 80, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15667578

ABSTRACT

The consequence of activating the nuclear hormone receptor, peroxisome proliferator-activated receptor gamma (PPARgamma), which coordinates adipocyte differentiation, validates the concept, 'you are what you eat'. Excessive caloric intake leads to fat formation if the energy from these nutrients is not expended. However, this evolutionary adaptation to store energy in fat, which can be released under the form of fatty acids, potent PPARgamma agonists, has become a disadvantage in today's affluent society as it results in numerous metabolic imbalances, collectively known as the metabolic syndrome. With the surge of human and genetic studies on PPARgamma function, the limitations to the benefits of PPARgamma signalling have been realized. It is now evident that the most effective strategy for resetting the balance of this thrifty gene is through its modulation rather than full activation, with the goal to improve glucose homeostasis while preventing adipogenesis. Finally, as more PPARgamma targeted pathways are revealed such as bone homeostasis, atherosclerosis and longevity, it is most certain that the PPARgamma thrifty gene hypothesis will evolve to incorporate these.


Subject(s)
Diabetes Mellitus, Type 2/metabolism , Insulin Resistance/physiology , Obesity/metabolism , PPAR gamma/metabolism , Adipose Tissue/metabolism , Animals , Arteriosclerosis/etiology , Arteriosclerosis/metabolism , Bone and Bones/metabolism , Homeostasis/physiology , Humans , Liver/metabolism , Longevity , Mice , Muscles/metabolism , PPAR gamma/genetics
3.
Arterioscler Thromb Vasc Biol ; 23(3): 475-82, 2003 Mar 01.
Article in English | MEDLINE | ID: mdl-12615696

ABSTRACT

OBJECTIVE: Peroxisome proliferator-activated receptor gamma (PPARgamma), a ligand-activated transcription factor, has pleiotropic effects, including regulation of macrophage differentiation and lipid homeostasis. The PPARgamma ligands, thiazolidinediones (TZDs), attenuate atherosclerosis in mice by uncertain mechanisms. The objective of this study was to determine whether activation of PPARgamma or its obligate heterodimer, retinoid X receptor (RXR), modulates macrophage foam cell formation induced by oxidized (ox) lipoproteins. METHODS AND RESULTS: Incubation of THP-1 macrophages with oxHTG-VLDL, oxREM, or oxLDL increased cellular cholesteryl ester over 6-fold. Preincubation with the TZD, ciglitazone, the RXR-specific ligand, 9-cis retinoic acid (9cRA) or the combination reduced CE mass accumulation by up to 65%. Ciglitazone and 9cRA increased CD36 mRNA (up to 4-fold); however, uptake of [125I]oxLDL was only modestly enhanced (up to 1.8-fold) becaues of a concomitant PPARgamma:RXR-induced decrease in SRAI/II activity (up to 40%). This suggested that PPARgamma:RXR activation inhibited cholesteryl ester accumulation by enhancing cholesterol efflux. Ciglitazone and 9cRA were found to increase the expression of ATP-binding cassette proteins A1 and G1, resulting in enhanced cholesterol efflux to lipoprotein-deficient serum, apoAI and HDL3. CONCLUSIONS: PPARgamma and/or RXR activation inhibit foam cell formation through enhanced cholesterol efflux despite increased oxLDL uptake. These observations explain the reduced atherosclerosis in TZD-treated mice and may extend the therapeutic implications of these ligands.


Subject(s)
Arteriosclerosis/metabolism , Cholesterol/metabolism , Lipoproteins/metabolism , Macrophages/metabolism , Receptors, Cytoplasmic and Nuclear/metabolism , Receptors, Retinoic Acid/metabolism , Transcription Factors/metabolism , ATP Binding Cassette Transporter 1 , ATP-Binding Cassette Transporters/metabolism , Animals , Humans , Membrane Transport Proteins/metabolism , Mice , Oxidation-Reduction , Retinoid X Receptors
4.
Arterioscler Thromb Vasc Biol ; 21(12): 2011-8, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11742878

ABSTRACT

Transforming growth factor beta1 (TGF-beta1) is secreted by various cells, including macrophages, smooth muscle cells, and endothelial cells. TGF-beta1 is present in atherosclerotic lesions, but its role in regulating macrophage foam cell formation is not understood. Hypertriglyceridemic very low density lipoprotein (VLDL) remnants (VLDL-REMs) in their native or oxidized form will induce cholesteryl ester (CE) and triglyceride (TG) accumulation in macrophages. Therefore, we examined whether TGF-beta1 can modulate the macrophage uptake of native or oxidized VLDL-REMs (oxVLDL-REMs). Incubation of J774A.1 macrophages with VLDL-REMs and oxVLDL-REMs compared with control cells increased cellular CE (13- and 21-fold, respectively) and TG mass (21-and 18-fold, respectively). Preincubation with TGF-beta1 before incubation with VLDL-REMs or oxVLDL-REMs significantly decreased CE (73% and 54%, respectively) and TG mass (42% and 41%, respectively). TGF-beta1 inhibited the activity and expression of 2 key components needed for VLDL-REM uptake: lipoprotein lipase and low density lipoprotein receptor. TGF-beta1 inhibited CE mass induced by oxVLDL-REMs in part by decreasing the expression of scavenger receptor type AI/II and CD36. Furthermore, TGF-beta1 enhanced cholesterol efflux through upregulation of the ATP-binding cassette (ABC) transporters ABCA1 and ABCG1. Thus, TGF-beta1 inhibits macrophage foam cell formation induced by VLDL-REMs or oxVLDL-REMs, which suggests an antiatherogenic role for this cytokine.


Subject(s)
Arteriosclerosis/metabolism , Cholesterol Esters/metabolism , Lipoproteins, VLDL/metabolism , Macrophages/metabolism , Transforming Growth Factor beta/metabolism , ATP Binding Cassette Transporter 1 , ATP Binding Cassette Transporter, Subfamily G, Member 1 , ATP-Binding Cassette Transporters/metabolism , Animals , Cells, Cultured , Down-Regulation , Humans , Lipid Metabolism , Lipoprotein Lipase/metabolism , Lipoproteins, LDL/metabolism , Mice , Oxidation-Reduction , RNA, Messenger/analysis , Receptors, Lipoprotein/genetics , Receptors, Lipoprotein/metabolism , Transforming Growth Factor beta1 , Up-Regulation
5.
J Lipid Res ; 40(6): 1017-28, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10357833

ABSTRACT

Hypertriglyceridemic (HTG) very low density lipoproteins (VLDL) from subjects with type IV hyperlipoproteinemia induce both cholesteryl ester (CE) and triglyceride (TG) accumulation in cultured J774 macrophages. We examined whether the cytokine interferon-gamma (IFN-gamma), which is expressed by lymphocytes in atherosclerotic lesions, would modulate macrophage uptake of HTG -VLDL. Incubation of cells with HTG -VLDL alone significantly increased cellular CE and TG mass 17- and 4.3-fold, respectively, while cellular free cholesterol (FC) was unaffected. Pre-incubation of cells with IFN-gamma (50 U/ml) prior to incubation with HTG -VLDL caused a marked enhancement in cellular CE and TG 27- and 6-fold over no additions (controls), respectively, and a 1.5-fold increase in FC. IFN-gamma increased low density lipoprotein (LDL)-induced cellular CE 2-fold compared to LDL alone. IFN-gamma did not enhance the uptake of type III (apoE2/E2) HTG -VLDL or VLDL from apoE knock-out mice. Incubations in the presence of a lipoprotein lipase (LPL) inhibitor or an acylCoA:cholesterol acyltransferase (ACAT) inhibitor demonstrated that the IFN-gamma-enhanced HTG -VLDL uptake was dependent on LPL and ACAT activities. IFN-gamma significantly increased the binding and degradation of 125I-labeled LDL. Binding studies with 125I-labeled alpha2-macroglobulin, a known LDL receptor-related protein (LRP) ligand, and experiments with copper-oxidized LDL indicated that the IFN-gamma-enhanced uptake was not due to increased expression of the LRP or scavenger receptors. Thus, IFN-gamma may promote foam cell formation by accelerating macrophage uptake of native lipoproteins. IFN-gamma-stimulated CE accumulation in the presence of HTG -VLDL occurs via a process that requires receptor binding-competent apoE and active LPL. IFN-gamma-enhanced uptake of both HTG -VLDL and LDL is mediated by the LDL-receptor and requires ACAT-mediated cholesterol esterification.


Subject(s)
Hypertriglyceridemia/blood , Interferon-gamma/pharmacology , Lipoproteins, VLDL/metabolism , Macrophages/metabolism , Animals , Apolipoproteins E/genetics , Cell Line , Cholesterol Esters/metabolism , Esterification , Humans , Lipoprotein Lipase/metabolism , Lipoproteins, LDL/metabolism , Lipoproteins, VLDL/blood , Mice , Mice, Inbred C57BL , Mice, Knockout , Oxidation-Reduction , Triglycerides/metabolism , alpha-Macroglobulins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...